A number of firms have modified their ratings and price targets on shares of Amrize (NYSE: AMRZ) recently:
- 11/9/2026 – Amrize was downgraded by Berenberg Bank from “buy” to “hold”. They now have a $46.00 price target on the stock, down from $48.00.
- 11/7/2026 – Amrize was downgraded by Wall Street Zen from “hold” to “sell”.
- 11/2/2026 – Amrize had its price target lowered by Oppenheimer from $55.00 to $52.00. They now have an “outperform” rating on the stock.
- 10/30/2026 – Amrize had its price target raised by DA Davidson from $40.00 to $43.00. They now have a “neutral” rating on the stock.
- 10/30/2026 – Amrize had its price target lowered by Wells Fargo & Company from $40.00 to $39.00. They now have an “equal weight” rating on the stock.
- 10/19/2026 – Amrize had its price target lowered by Barclays from $55.00 to $40.00. They now have an “equal weight” rating on the stock.
- 10/13/2026 – Amrize had its price target lowered by JPMorgan Chase & Co. from $52.00 to $48.00. They now have a “neutral” rating on the stock.
- 10/12/2026 – Amrize is now covered by Longbow Research. They set a “buy” rating on the stock.
- 10/9/2026 – Amrize was given a new $40.00 price target by DA Davidson.
- 10/9/2026 – Amrize had its price target lowered by Royal Bank Of Canada from $48.00 to $32.00. They now have an “underperform” rating on the stock.
- 10/8/2026 – Amrize was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
- 10/5/2026 – Amrize had its price target lowered by Wells Fargo & Company from $44.00 to $40.00. They now have an “equal weight” rating on the stock.
- 10/5/2026 – Amrize had its price target lowered by Truist Financial from $48.00 to $35.00. They now have a “hold” rating on the stock.
- 10/2/2026 – Amrize had its price target lowered by Citigroup from $58.00 to $50.00. They now have a “buy” rating on the stock.
- 10/1/2026 – Amrize is now covered by Barclays. They set an “equal weight” rating and a $55.00 price target on the stock.
- 10/1/2026 – Amrize is now covered by Barclays. They set an “equal weight” rating and a $55.00 price target on the stock.
- 9/23/2026 – Amrize had its price target lowered by Deutsche Bank Aktiengesellschaft from $64.00 to $56.00. They now have a “buy” rating on the stock.
- 9/22/2026 – Amrize had its price target lowered by UBS Group from $57.00 to $42.00. They now have a “neutral” rating on the stock.
- 9/21/2026 – Amrize had its “outperform” rating reaffirmed by Sanford C. Bernstein. They now have a $60.00 price target on the stock.
- 9/18/2026 – Amrize had its price target lowered by Oppenheimer from $62.00 to $55.00. They now have an “outperform” rating on the stock.
Amrize Trading Down 0.8%
NYSE AMRZ opened at $41.63 on Wednesday. The business’s 50-day moving average price is $39.46 and its two-hundred day moving average price is $50.18. Amrize Ltd has a 12 month low of $35.78 and a 12 month high of $65.94. The firm has a market capitalization of $23.03 billion, a PE ratio of 18.84, a price-to-earnings-growth ratio of 1.68 and a beta of 0.04. The company has a current ratio of 1.07, a quick ratio of 0.67 and a debt-to-equity ratio of 0.33.
Amrize (NYSE:AMRZ – Get Free Report) last announced its earnings results on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, meeting the consensus estimate of $1.05. The company had revenue of $3.77 billion for the quarter. Amrize had a return on equity of 10.02% and a net margin of 9.93%. The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.98 EPS. On average, analysts expect that Amrize Ltd will post 2.30 EPS for the current year.
Amrize Dividend Announcement
The business also recently disclosed a dividend, which will be paid on Wednesday, November 18th. Shareholders of record on Tuesday, November 10th will be paid a dividend of $0.11 per share. The ex-dividend date is Tuesday, November 10th. Amrize’s dividend payout ratio (DPR) is 4.98%.
Insiders Place Their Bets
In other news, CEO Jan Jenisch bought 26,000 shares of the company’s stock in a transaction on Wednesday, September 2nd. The shares were purchased at an average price of $42.47 per share, with a total value of $1,104,220.00. Following the transaction, the chief executive officer directly owned 1,767,000 shares in the company, valued at $75,044,490. This represents a 1.49% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jacques Sanche bought 4,150 shares of Amrize stock in a transaction dated Wednesday, August 26th. The stock was acquired at an average cost of $45.02 per share, with a total value of $186,833.00. Following the completion of the acquisition, the director owned 9,766 shares of the company’s stock, valued at $439,665.32. This represents a 73.90% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 34,155 shares of company stock worth $1,461,276 over the last ninety days. Insiders own 0.54% of the company’s stock.
Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.
Featured Stories
- Five stocks we like better than Amrize
- Alphabet Escalates AI Chip Rivalry With NVIDIA
- Amazon’s Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?
- 3 Stocks Wall Street Likes More Than the Market Does
- Anthropic’s Trillion-Dollar IPO Could Give Cloud Giants a Double Win
Receive News & Ratings for Amrize Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize Ltd and related companies with MarketBeat.com's FREE daily email newsletter.
